Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The role of genetics in Crohn's disease: how could it influence future therapies?

Geremia A, Satsangi J.

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1075-1077. doi: 10.1080/17474124.2018.1513323. Epub 2018 Aug 21. No abstract available.

PMID:
30124365
2.

CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.

Kurioka A, Cosgrove C, Simoni Y, van Wilgenburg B, Geremia A, Björkander S, Sverremark-Ekström E, Thurnheer C, Günthard HF, Khanna N; Swiss HIV Cohort Study; Oxford IBD Cohort Investigators, Walker LJ, Arancibia-Cárcamo CV, Newell EW, Willberg CB, Klenerman P.

Front Immunol. 2018 Apr 9;9:486. doi: 10.3389/fimmu.2018.00486. eCollection 2018.

3.

Innate Lymphoid Cells in Intestinal Inflammation.

Geremia A, Arancibia-Cárcamo CV.

Front Immunol. 2017 Oct 13;8:1296. doi: 10.3389/fimmu.2017.01296. eCollection 2017. Review.

4.

Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.

Gwela A, Siddhanathi P, Chapman RW, Travis S, Powrie F, Arancibia-Cárcamo CV, Geremia A.

J Crohns Colitis. 2017 Sep 1;11(9):1124-1134. doi: 10.1093/ecco-jcc/jjx050.

5.

A Primary-Care Interventional Model on the Diverticular Disease: Searching for the Optimal Therapeutic Schedule.

Campanini A, De Conto U, Cavasin F, Bastiani F, Camarotto A, Gardini L, Geremia A, Marastoni C, Missorini C, Quarantelli E, Sassi U, Scarabello F, Dal Bo N, Riccò M, Grillo S, Landi S, Di Mario F.

J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S93-6. doi: 10.1097/MCG.0000000000000670.

PMID:
27622379
6.

Innate and adaptive immunity in inflammatory bowel disease.

Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A.

Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15. Review.

PMID:
23774107
7.

The IL-23/IL-17 pathway in inflammatory bowel disease.

Geremia A, Jewell DP.

Expert Rev Gastroenterol Hepatol. 2012 Apr;6(2):223-37. doi: 10.1586/egh.11.107. Review.

PMID:
22375527
8.

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells.

Walker LJ, Kang YH, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, Sahgal N, Leslie A, Oo Y, Geremia A, Scriba TJ, Hanekom WA, Lauer GM, Lantz O, Adams DH, Powrie F, Barnes E, Klenerman P.

Blood. 2012 Jan 12;119(2):422-33. doi: 10.1182/blood-2011-05-353789. Epub 2011 Nov 15.

9.

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.

Geremia A, Arancibia-Cárcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F.

J Exp Med. 2011 Jun 6;208(6):1127-33. doi: 10.1084/jem.20101712. Epub 2011 May 16.

10.

Association of caspase-9 and RUNX3 with inflammatory bowel disease.

Guo C, Ahmad T, Beckly J, Cummings JR, Hancock L, Geremia A, Cooney R, Pathan S, Jewell DP.

Tissue Antigens. 2011 Jan;77(1):23-9. doi: 10.1111/j.1399-0039.2010.01569.x. Epub 2010 Sep 30.

PMID:
20887385
11.

The genetics of NOD-like receptors in Crohn's disease.

Cummings JR, Cooney RM, Clarke G, Beckly J, Geremia A, Pathan S, Hancock L, Guo C, Cardon LR, Jewell DP.

Tissue Antigens. 2010 Jul;76(1):48-56. doi: 10.1111/j.1399-0039.2010.01470.x. Epub 2010 Apr 6.

PMID:
20403135
12.

Association between genetic variants in myosin IXB and Crohn's disease.

Cooney R, Cummings JR, Pathan S, Beckly J, Geremia A, Hancock L, Guo C, Morris A, Jewell DP.

Inflamm Bowel Dis. 2009 Jul;15(7):1014-21. doi: 10.1002/ibd.20885.

PMID:
19235913
13.

Clinical and molecular characteristics of isolated colonic Crohn's disease.

Hancock L, Beckly J, Geremia A, Cooney R, Cummings F, Pathan S, Guo C, Warren BF, Mortensen N, Ahmad T, Jewell D.

Inflamm Bowel Dis. 2008 Dec;14(12):1667-77. doi: 10.1002/ibd.20517.

PMID:
18521924
14.

Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease.

Beckly JB, Hancock L, Geremia A, Cummings JR, Morris A, Cooney R, Pathan S, Guo C, Jewell DP.

Inflamm Bowel Dis. 2008 Apr;14(4):500-7. doi: 10.1002/ibd.20365.

PMID:
18200509
15.

Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.

Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP.

Inflamm Bowel Dis. 2007 Sep;13(9):1063-8.

PMID:
17508420
16.

Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene.

Cummings JR, Cooney R, Pathan S, Anderson CA, Barrett JC, Beckly J, Geremia A, Hancock L, Guo C, Ahmad T, Cardon LR, Jewell DP.

Inflamm Bowel Dis. 2007 Aug;13(8):941-6.

PMID:
17455206
17.

Local injection of infliximab in the postoperative recurrence of Crohn's disease.

Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, Calabrese E, Pallone F.

Gastrointest Endosc. 2006 Mar;63(3):486-92.

PMID:
16500402
18.

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.

Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benazzato L, Papi C, Meucci G, Riegler G, Petruzziello C, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F.

Gut. 2006 Feb;55(2):228-33. Epub 2005 Aug 24.

19.

Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.

Orlando A, Colombo E, Kohn A, Biancone L, Rizzello F, Viscido A, Sostegni R, Benazzato L, Castiglione F, Papi C, Meucci G, Riegler G, Mocciaro F, Cassinotti A, Cosintino R, Geremia A, Morselli C, Angelucci E, Lavagna A, Rispo A, Bossa F, Scimeca D, Cottone M; Italian Multicentric Study Group on Infliximab.

Dig Liver Dis. 2005 Aug;37(8):577-83.

PMID:
15886081
20.

Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration.

Biancone L, Schillaci O, Capoccetti F, Bozzi RM, Fina D, Petruzziello C, Geremia A, Simonetti G, Pallone F.

Am J Gastroenterol. 2005 Feb;100(2):344-54.

PMID:
15667492
21.

Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.

Biancone L, Tosti C, Geremia A, Fina D, Petruzziello C, Emerenziani S, Pallone F.

Aliment Pharmacol Ther. 2004 Apr 1;19(7):755-64.

22.

Review article: maintenance treatment of Crohn's disease.

Biancone L, Tosti C, Fina D, Fantini M, De Nigris F, Geremia A, Pallone F.

Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:31-7. Review.

23.

Review article: monitoring the activity of Crohn's disease.

Biancone L, De Nigris F, Del Vecchio Blanco G, Monteleone I, Vavassori P, Geremia A, Pallone F.

Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:29-33. Review.

24.

The living factory: in vivo production of N-acetyllactosamine containing carbohydrates in E. coli.

Bettler E, Samain E, Chazalet V, Bosso C, Heyraud A, Joziasse DH, Wakarchuk WW, Imberty A, Geremia AR.

Glycoconj J. 1999 Mar;16(3):205-12.

PMID:
10596895
25.

[Case of flaccid paraplegia caused by compression of the cauda equina by posterior median lumbar disk herniation].

GEREMIA A, PRANDO L.

Athena. 1957 Jun;23(6):205-11. Italian. No abstract available.

PMID:
13459822
26.

[Comparative study of the effect of atropine and ganglion-blocking on the secretory and motor function of the stomach].

GEREMIA A, REBESCHINI V.

Minerva Med. 1955 May 5;46(36):1293-8. Italian. No abstract available.

PMID:
14393790
27.

Clinical features of patent ductus arteriosus with special reference to cardiac murmurs.

LEVINE SA, GEREMIA AE.

Am J Med Sci. 1947 Apr;213(4):385-94. No abstract available.

PMID:
20291268
28.

The ausculatory findings in patent ductus arteriosus.

LEVINE SA, GEREMIA AE.

Bull New Engl Med Cent. 1946 Aug;8(4):148-51. No abstract available.

PMID:
20285230

Supplemental Content

Loading ...
Support Center